Havemeyer Place LP Acquires New Shares in Astera Labs, Inc. $ALAB

Havemeyer Place LP acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 8,332 shares of the company’s stock, valued at approximately $1,386,000.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Lido Advisors LLC raised its holdings in shares of Astera Labs by 0.5% in the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after acquiring an additional 57 shares in the last quarter. Perigon Wealth Management LLC raised its holdings in shares of Astera Labs by 6.2% in the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock valued at $208,000 after acquiring an additional 73 shares in the last quarter. Clearstead Advisors LLC raised its holdings in shares of Astera Labs by 13.6% in the third quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock valued at $125,000 after acquiring an additional 76 shares in the last quarter. Sound Income Strategies LLC raised its holdings in Astera Labs by 9.2% in the fourth quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after purchasing an additional 76 shares in the last quarter. Finally, Venturi Wealth Management LLC raised its holdings in Astera Labs by 2.6% in the fourth quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock worth $546,000 after purchasing an additional 84 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors.

Insider Activity

In other news, COO Sanjay Gajendra sold 400,000 shares of the company’s stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the transaction, the chief operating officer owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This represents a 7.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of the company’s stock in a transaction dated Friday, April 17th. The shares were sold at an average price of $172.14, for a total transaction of $56,064,793.02. Following the transaction, the chief executive officer owned 4,079,322 shares in the company, valued at approximately $702,214,489.08. This trade represents a 7.39% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 2,311,256 shares of company stock worth $477,341,446 over the last 90 days. 10.40% of the stock is currently owned by corporate insiders.

Astera Labs Price Performance

ALAB opened at $317.06 on Monday. Astera Labs, Inc. has a 52-week low of $84.78 and a 52-week high of $372.37. The company has a market cap of $54.35 billion, a P/E ratio of 214.23, a price-to-earnings-growth ratio of 4.20 and a beta of 3.95. The firm’s 50-day moving average price is $212.95 and its 200-day moving average price is $171.81.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same quarter in the prior year, the company posted $0.33 earnings per share. The company’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts anticipate that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 26th. TD Cowen boosted their target price on shares of Astera Labs from $140.00 to $225.00 and gave the stock a “hold” rating in a report on Wednesday, May 6th. Stifel Nicolaus boosted their target price on shares of Astera Labs from $236.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Rothschild & Co Redburn assumed coverage on shares of Astera Labs in a report on Friday, May 1st. They issued a “neutral” rating and a $153.00 target price for the company. Finally, UBS Group assumed coverage on shares of Astera Labs in a report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 target price for the company. Twelve research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $233.75.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.